How to measure insulin action in vivo (Q72795603)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7956677%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

review article

1 reference

title

How to measure insulin action in vivo (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7956677%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

Scheen AJ

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7956677%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

Paquot N

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7956677%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

Castillo MJ

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7956677%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

Lefèbvre PJ

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7956677%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

publication date

1 July 1994

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7956677%20AND%20SRC:MED&resulttype=core&format=json

Diabetes/metabolism reviews

29 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7956677%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7956677%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7956677%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

page(s)

151-188

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7956677%20AND%20SRC:MED&resulttype=core&format=json

Assessment of insulin sensitivity in vivo

29 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100206

7 January 2021

Quantitative modelling of endocrine diseases as exemplified by diabetes

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100206

7 January 2021

https://api.crossref.org/works/10.1002%2FDMR.5610100206

1 reference

7 January 2021

Insulin sensitivity in the intact organism

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100206

7 January 2021

Measurement by microdialysis of the insulin concentration in subcutaneous interstitial fluid. Importance of the endothelial barrier for insulin

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100206

7 January 2021

Some thoughts on the mechanism of action of insulin

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100206

7 January 2021

Insulin resistance--mechanisms, syndromes, and implications

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100206

7 January 2021

Banting lecture 1988. Role of insulin resistance in human disease

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100206

7 January 2021

Insulin sensitivity in anorexia nervosa: a mirror image of obesity?

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100206

7 January 2021

Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100206

7 January 2021

Variations in insulin-stimulated glucose uptake in healthy individuals with normal glucose tolerance.

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100206

7 January 2021

Demonstration of a Relationship Between Level of Physical Training and Insulin-stimulated Glucose Utilization in Normal Humans

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100206

7 January 2021

Diurnal variation in glucose tolerance. Cyclic suppression of insulin action and insulin secretion in normal-weight, but not obese, subjects

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100206

7 January 2021

Insulin resistance, insulin insensitivity, and insulin unresponsiveness: a necessary distinction

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100206

7 January 2021

LIlly lecture 1980. Insulin resistance and insulin action. An in vitro and in vivo perspective

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100206

7 January 2021

New concepts in the pathogenesis and treatment of noninsulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100206

7 January 2021

Insulin resistance in noninsulin-dependent diabetes mellitus. Does it exist and can it be measured?

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100206

7 January 2021

Assessment of Insulin Resistance in vivo: Application to the Study of Type 2 Diabetes

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100206

7 January 2021

Insulin resistance and insulin deficiency in the pathogenesis of type 2 (non-insulin-dependent) diabetes mellitus: errors of metabolism or of methods?

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100206

7 January 2021

https://api.crossref.org/works/10.1002%2FDMR.5610100206

1 reference

7 January 2021

Intravenous Glucose Tolerance as a Tool in Definition and Diagnosis of Diabetes Mellitus

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100206

7 January 2021

The significance and interpretation of mildly abnormal oral glucose tolerance

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100206

7 January 2021

Normalization of the insulin sensitivity and the cellular insulin binding during treatment of obese diabetics for one year

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100206

7 January 2021

Glucose kinetics in human obesity

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100206

7 January 2021

Glucose dynamics in normal subjects and diabetic patients before and after a glucose load

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100206

7 January 2021

Physiologic evaluation of factors controlling glucose tolerance in man: measurement of insulin sensitivity and beta-cell glucose sensitivity from the response to intravenous glucose

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100206

7 January 2021

Plasma insulin concentrations in nondiabetic and early diabetic subjects. Determinations by a new sensitive immuno-assay technic

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100206

7 January 2021

Excessive Insulin Response to Glucose in Obese Subjects as Measured by Immunochemical Assay

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100206

7 January 2021

Study of the Relationship Between Glucose and Insulin Responses to an Oral Glucose Load in Man

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100206

7 January 2021

Influences of glucose loading and of injected insulin on hepatic glucose output

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100206

7 January 2021

Measurement of circulating intermediary metabolites

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100206

7 January 2021

Measurement of the turnover of substrates of carbohydrate and protein metabolism using radioactive isotopes

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100206

7 January 2021

Banting Lecture: glucose turnover. A key to understanding the pathogenesis of diabetes (indirect effects of insulin).

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100206

7 January 2021

Effect of insulin on the distribution and disposition of glucose in man.

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100206

7 January 2021

Modeling of insulin action in vivo

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100206

7 January 2021

On the determination of basal glucose production rate in patients with type 2 (non-insulin-dependent) diabetes mellitus using primed-continuous 3-3H-glucose infusion

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100206

7 January 2021

Underestimation of glucose turnover measured with [6-3H]- and [6,6-2H]- but not [6-14C]glucose during hyperinsulinemia in humans

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100206

7 January 2021

Hepatic and extrahepatic responses to insulin in NIDDM and nondiabetic humans. Assessment in absence of artifact introduced by tritiated nonglucose contaminants.

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100206

7 January 2021

Underestimation of glucose turnover determined using [6-3H]glucose tracer in non-steady state. The role of a tritiated tracer impurity

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100206

7 January 2021

Modeling error and apparent isotope discrimination confound estimation of endogenous glucose production during euglycemic glucose clamps.

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100206

7 January 2021

Mechanism for underestimation of isotopically determined glucose disposal

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100206

7 January 2021

Assessment of glucose turnover rates in euglycaemic clamp studies using primed-constant [3-3H]-glucose infusion and labelled or unlabelled glucose infusates

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100206

7 January 2021

The disposal of an oral glucose load in healthy subjects. A quantitative study

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100206

7 January 2021

Skeletal muscle glycolysis, oxidation, and storage of an oral glucose load

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100206

7 January 2021

Pathogenesis of NIDDM. A balanced overview

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100206

7 January 2021

The measurement of metabolite exchange across muscle beds

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100206

7 January 2021

Use of the splanchnic/hepatic balance technique in the study of glucose metabolism

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100206

7 January 2021

The quantitatively minor role of carbohydrate in oxidative metabolism by skeletal muscle in intact man in the basal state; measurements of oxygen and glucose uptake and carbon dioxide and lactate production in the forearm

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100206

7 January 2021

THEORY OF THE USE OF ARTERIOVENOUS CONCENTRATION DIFFERENCES FOR MEASURING METABOLISM IN STEADY AND NON-STEADY STATES.

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100206

7 January 2021

Glucose uptake in human adipose tissue

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100206

7 January 2021

The effect of insulin on the disposal of intravenous glucose. Results from indirect calorimetry and hepatic and femoral venous catheterization

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100206

7 January 2021

Forearm metabolism in obesity and its response to intra-arterial insulin. Characterization of insulin resistance and evidence for adaptive hyperinsulinism

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100206

7 January 2021

Relationship Between the Basal Glucose Concentration Glucose Tolerance and Forearm Glucose Uptake in Maturity-onset Diabetes

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100206

7 January 2021

Insulin responsiveness of superficial forearm tissues in type 2 (non-insulin dependent) diabetes

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100206

7 January 2021

Effects of insulin on peripheral and splanchnic glucose metabolism in noninsulin-dependent (type II) diabetes mellitus

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100206

7 January 2021

Contribution of abnormal muscle and liver glucose metabolism to postprandial hyperglycemia in NIDDM.

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100206

7 January 2021

Metabolic pathways of glucose in skeletal muscle of lean NIDDM patients

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100206

7 January 2021

Characterization of cellular defects of insulin action in type 2 (non-insulin-dependent) diabetes mellitus

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100206

7 January 2021

Kinetics of glucose disposal in whole body and across the forearm in man.

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100206

7 January 2021

Glucose transport in human skeletal muscle. The in vivo response to insulin

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100206

7 January 2021

Influence of Endogenous Insulin Secretion on Splanchnic Glucose and Amino Acid Metabolism in Man

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100206

7 January 2021

Splanchnic and peripheral disposal of oral glucose in man

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100206

7 January 2021

Regulation of Splanchnic and Peripheral Glucose Uptake by Insulin and Hyperglycemia in Man

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100206

7 January 2021

Regulation of hepatic glucose metabolism in humans

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100206

7 January 2021

Comparison of impedance to insulin-mediated glucose uptake in normal subjects and in subjects with latent diabetes

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100206

7 January 2021

Glucose, insulin and somatostatin infusion for the determination of insulin sensitivity

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100206

7 January 2021

Nonketotic diabetes mellitus: insulin deficiency or insulin resistance?

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100206

7 January 2021

A Simplified Method Using Somatostatin to Assess In Vivo Insulin Resistance over a Range of Obesity

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100206

7 January 2021

Evaluation of insulin resistance during inhibition of endogenous insulin and glucagon secretion by somatostatin in non-obese subjects with impaired glucose tolerance

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100206

7 January 2021

Clinical significance of altered insulin sensitivity in diabetes mellitus assessed by glucose, insulin, and somatostatin infusion

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100206

7 January 2021

Insulin insensitivity in offspring of parents with type 2 diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100206

7 January 2021

Assessment of insulin resistance with the insulin suppression test and the euglycemic clamp

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100206

7 January 2021

A model of the kinetics of insulin in man.

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100206

7 January 2021

Insulin control of glucose metabolism in man: a new kinetic analysis

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100206

7 January 2021

Resistance to insulin suppression of plasma free fatty acid concentrations and insulin stimulation of glucose uptake in noninsulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100206

7 January 2021

Glucose and free fatty acid metabolism in non-insulin-dependent diabetes mellitus. Evidence for multiple sites of insulin resistance

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100206

7 January 2021

Glucose clamping using the Biostator GCIIS

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100206

7 January 2021

A comparison of the artificial pancreas (glucose controlled insulin infusion system) and a manual technique for assessing insulin sensitivity during euglycaemic clamping.

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100206

7 January 2021

A minimal-model-based glucose clamp yielding insulin sensitivity independent of glycemia.

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100206

7 January 2021

PACBERG: An adaptive program for controlling the blood sugar

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100206

7 January 2021

Unbiased and flexible iterative computer program to achieve glucose clamping

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100206

7 January 2021

Can mixed venous blood be used to measure insulin action during the hyperinsulinemic clamp?

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100206

7 January 2021

Effects of arterial versus venous sampling on analysis of glucose kinetics in man.

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100206

7 January 2021

Enhanced glucose utilization during prolonged glucose clamp studies

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100206

7 January 2021

Insulin-stimulated glucose disposal increases with time in patients with non-insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100206

7 January 2021

Effect of variations in basal plasma glucose concentration on glucose utilization (M) and metabolic clearance (MCR) rates during insulin clamp studies in patients with non-insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100206

7 January 2021

Glucose disposal is not proportional to plasma glucose level in man.

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100206

7 January 2021

Effects of Plasma Glucose Concentration on Glucose Utilization and Glucose Clearance in Normal Man

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100206

7 January 2021

Influence of plasma glucose and insulin concentration on plasma glucose clearance in man

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100206

7 January 2021

The physiologic action of insulin on glucose uptake and its relevance to the interpretation of the metabolic clearance rate of glucose

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100206

7 January 2021

Use of glucose uptake and glucose clearance for the evaluation of insulin action in vivo.

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100206

7 January 2021

The metabolic clearance of glucose: measurement and meaning

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100206

7 January 2021

Presentation of a new method for specific measurement of in vivo insulin-stimulated glucose disposal in humans: comparison of this approach with the insulin clamp and minimal model techniques

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100206

7 January 2021

In vivo kinetics of insulin action on peripheral glucose disposal and hepatic glucose output in normal and obese subjects

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100206

7 January 2021

Use of a variable insulin infusion to assess insulin action in obesity: defects in both the kinetics and amplitude of response.

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100206

7 January 2021

Kinetics of insulin-mediated and non-insulin-mediated glucose uptake in humans

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100206

7 January 2021

Kinetics of in vivo muscle insulin-mediated glucose uptake in human obesity

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100206

7 January 2021

Rates of noninsulin-mediated glucose uptake are elevated in type II diabetic subjects

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100206

7 January 2021

Differential effects of insulin and hyperglycemia on intracellular glucose disposition in humans

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100206

7 January 2021

Effect of hyperinsulinemia and hyperglycemia on intracellular glucose and fat metabolism in healthy subjects

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100206

7 January 2021

Insulin increases the maximum velocity for glucose uptake without altering the Michaelis constant in man. Evidence that insulin increases glucose uptake merely by providing additional transport sites

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100206

7 January 2021

Insulin responses to varying profiles of subcutaneous insulin infusion: kinetic modelling studies

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100206

7 January 2021

The influence of graded hyperglycemia with and without physiological hyperinsulinemia on forearm glucose uptake and other metabolic responses in man.

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100206

7 January 2021

Mechanism of enhanced insulin sensitivity in athletes. Increased blood flow, muscle glucose transport protein (GLUT-4) concentration, and glycogen synthase activity

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100206

7 January 2021

Effect of free fatty acids on glucose uptake and nonoxidative glycolysis across human forearm tissues in the basal state and during insulin stimulation

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100206

7 January 2021

Localization of rate-limiting defect for glucose disposal in skeletal muscle of insulin-resistant type I diabetic patients.

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100206

7 January 2021

Influence of combined intravenous and oral glucose administration on splanchnic glucose uptake in man

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100206

7 January 2021

https://api.crossref.org/works/10.1002%2FDMR.5610100206

1 reference

7 January 2021

Assessment of energy expenditure and fuel utilization in man.

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100206

7 January 2021

The theoretical bases of indirect calorimetry: a review

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100206

7 January 2021

Comparison of extracellular and net glucose oxidation measured isotopically and by indirect calorimetry during high and low glucose turnover

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100206

7 January 2021

Role of lipid oxidation in pathogenesis of insulin resistance of obesity and type II diabetes

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100206

7 January 2021

Metabolic origin of insulin resistance in obesity with and without type 2 (non-insulin-dependent) diabetes mellitus

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100206

7 January 2021

Use of adipose tissue for metabolic studies

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100206

7 January 2021

Human liver in vitro techniques for metabolic studies

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100206

7 January 2021

Insulin receptor kinase defects in insulin-resistant tissues and their role in the pathogenesis of NIDDM.

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100206

7 January 2021

Correlation of in vivo and in vitro actions of insulin in obesity and noninsulin-dependent diabetes mellitus: role of the glucose transport system

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100206

7 January 2021

Glucose transport and glucose transporters in muscle and their metabolic regulation

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100206

7 January 2021

Correlation between muscle glycogen synthase activity and in vivo insulin action in man.

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100206

7 January 2021

Regulation of glycogen synthase and phosphorylase activities by glucose and insulin in human skeletal muscle

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100206

7 January 2021

Intracellular defects in glucose metabolism in obese patients with NIDDM.

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100206

7 January 2021

Microdialysis--a novel technique for clinical investigations

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100206

7 January 2021

Assessment of adipose tissue metabolism in man: comparison of Fick and microdialysis techniques

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100206

7 January 2021

Effects of insulin deprivation and replacement on in vivo subcutaneous adipose tissue substrate metabolism in humans

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100206

7 January 2021

Effect of insulin on human adipose tissue metabolism in situ. Interactions with beta-adrenoceptors

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100206

7 January 2021

Validation of a practical in vivo insulin dose-response curve in man.

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100206

7 January 2021

The effect of graded doses of insulin on total glucose uptake, glucose oxidation, and glucose storage in man

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100206

7 January 2021

Effect of training on the dose-response relationship for insulin action in men.

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100206

7 January 2021

Mechanisms of insulin resistance in human obesity: evidence for receptor and postreceptor defects

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100206

7 January 2021

Obesity and insulin resistance in humans: a dose-response study.

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100206

7 January 2021

Receptor and postreceptor defects contribute to the insulin resistance in noninsulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100206

7 January 2021

Mechanism and significance of insulin resistance in non-insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100206

7 January 2021

Quantification of the relative impairment in actions of insulin on hepatic glucose production and peripheral glucose uptake in non-insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100206

7 January 2021

Improvement of insulin-induced glucose disposal in obese patients with NIDDM after 1-wk treatment with d-fenfluramine

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100206

7 January 2021

Application of modelling techniques to the assessment of insulin sensitivity in man.

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100206

7 January 2021

Lilly lecture 1989. Toward physiological understanding of glucose tolerance. Minimal-model approach

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100206

7 January 2021

Measurement of insulin secretion in type 2 diabetes: problems and pitfalls

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100206

7 January 2021

Insulin deficiency and insulin resistance interaction in diabetes: estimation of their relative contribution by feedback analysis from basal plasma insulin and glucose concentrations

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100206

7 January 2021

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100206

7 January 2021

Determinants of estimated insulin resistance and beta-cell function in Indian, Creole and Chinese Mauritians. The Mauritius NCD Study Group

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100206

7 January 2021

Relative contributions of insulin deficiency and insulin resistance in maturity-onset diabetes.

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100206

7 January 2021

Natural history of pancreatic islet B-cell function in type 2 diabetes mellitus studied over six years by homeostasis model assessment

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100206

7 January 2021

Understanding "insulin resistance": both glucose resistance and insulin resistance are required to model human diabetes

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100206

7 January 2021

Steady State Plasma Insulin Response to Continuous Glucose Infusion in Normal and Diabetic Subjects

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100206

7 January 2021

Continuous infusion of glucose with model assessment: measurement of insulin resistance and beta-cell function in man.

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100206

7 January 2021

Prednisolone enhances beta-cell function independently of ambient glycemic levels in type II diabetes

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100206

7 January 2021

Beta-cell dysfunction, rather than insulin insensitivity, is the primary defect in familial type 2 diabetes.

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100206

7 January 2021

Hyperglycaemic progression in subjects with impaired glucose tolerance: association with decline in beta cell function

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100206

7 January 2021

MINMOD: a computer program to calculate insulin sensitivity and pancreatic responsivity from the frequently sampled intravenous glucose tolerance test.

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100206

7 January 2021

Application of the SAAM modeling program to minimal model analysis of intravenous glucose tolerance test data

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100206

7 January 2021

A program to estimate insulin sensitivity and pancreatic responsivity from an IVGTT using the minimal modeling technique

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100206

7 January 2021

Importance of glucose per se to intravenous glucose tolerance. Comparison of the minimal-model prediction with direct measurements.

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100206

7 January 2021

Reduced sample number for calculation of insulin sensitivity and glucose effectiveness from the minimal model. Suitability for use in population studies

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100206

7 January 2021

Reduced sampling protocols in estimation of insulin sensitivity and glucose effectiveness using the minimal model in NIDDM.

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100206

7 January 2021

The modified minimal model: application to measurement of insulin sensitivity in children.

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100206

7 January 2021

Quantification of the relationship between insulin sensitivity and beta-cell function in human subjects. Evidence for a hyperbolic function

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100206

7 January 2021

Relationship of islet function to insulin action in human obesity

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100206

7 January 2021

The insulin sensitivity index in nondiabetic man. Correlation between clamp-derived and IVGTT-derived values.

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100206

7 January 2021

A modified protocol for estimation of insulin sensitivity with the minimal model of glucose kinetics in patients with insulin-dependent diabetes

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100206

7 January 2021

Minimal model analysis of intravenous glucose tolerance test-derived insulin sensitivity in diabetic subjects

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100206

7 January 2021

A modified minimal model analysis of insulin sensitivity and glucose-mediated glucose disposal in insulin-dependent diabetes

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100206

7 January 2021

Stable-label intravenous glucose tolerance test minimal model

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100206

7 January 2021

Minimal Models of Glucose Disappearance: Lessons from the Labelled IVGTT

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100206

7 January 2021

Estimates of in vivo insulin action in humans: comparison of the insulin clamp and the minimal model techniques.

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100206

7 January 2021

Equivalence of the insulin sensitivity index in man derived by the minimal model method and the euglycemic glucose clamp

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100206

7 January 2021

Glucose disposal, beta-cell secretion, and hepatic insulin extraction in cirrhosis: a minimal model assessment

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100206

7 January 2021

Effects of prolonged pulsatile hyperinsulinemia in humans. Enhancement of insulin sensitivity

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100206

7 January 2021

Insulin secretion, insulin sensitivity and glucose-mediated glucose disposal in thyrotoxicosis: a minimal model analysis

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100206

7 January 2021

Islet function and insulin sensitivity in the non-diabetic offspring of conjugal type 2 diabetic patients

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100206

7 January 2021

Insulin secretion, insulin sensitivity and glucose-mediated glucose disposal in Cushing's disease: a minimal model analysis

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100206

7 January 2021

Role of glucose and insulin resistance in development of type 2 diabetes mellitus: results of a 25-year follow-up study

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100206

7 January 2021

Danazol induces resistance to both insulin and glucagon in young women

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100206

7 January 2021

Familial Clustering of Insulin Sensitivity

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100206

7 January 2021

Insulin resistance, secretion, and elimination in postmenopausal women receiving oral or transdermal hormone replacement therapy.

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100206

7 January 2021

The effects of the menopause on insulin sensitivity, secretion and elimination in non-obese, healthy women

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100206

7 January 2021

Insulin sensitivity and beta-cell responsivity are not decreased in elderly subjects with normal OGTT.

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100206

7 January 2021

Diminished insulin sensitivity and increased insulin response in nonobese, nondiabetic Mexican Americans

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100206

7 January 2021

Insulin Sensitivity, Glucose Effectiveness, and Body Fat Distribution Pattern in Nondiabetic Offspring of Patients With NIDDM

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100206

7 January 2021

Intravenous glucose tolerance test-derived insulin sensitivity changes during the menstrual cycle

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100206

7 January 2021

Insulin resistance in obesity is associated with elevated basal lactate levels and diminished lactate appearance following intravenous glucose and insulin

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100206

7 January 2021

Insulin sensitivity, insulin secretion, and glucose effectiveness in anorexia nervosa: a minimal model analysis

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100206

7 January 2021

Insulin sensitivity, insulin secretion and glucose effectiveness in diabetic and non-diabetic cirrhotic patients

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100206

7 January 2021

Insulin sensitivity and body fat distribution in normotensive offspring of hypertensive parents

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100206

7 January 2021

Effect of heparin on insulin-glucose interactions measured by the minimal model technique: Implications for reproducibility using this method

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100206

7 January 2021

Reproducibility of insulin sensitivity measured by the minimal model method

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100206

7 January 2021

Beta-cell function and insulin sensitivity in nondiabetic HLA-identical siblings of insulin-dependent diabetics.

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100206

7 January 2021

Determinants of clinical remission in recent-onset IDDM.

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100206

7 January 2021

Pathogenic factors responsible for glucose intolerance in patients with NIDDM

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100206

7 January 2021

Derivation of a quantitative measure of insulin sensitivity from the intravenous tolbutamide test using the minimal model of glucose dynamics

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100206

7 January 2021

Estimates of in vivo insulin action in man: comparison of insulin tolerance tests with euglycemic and hyperglycemic glucose clamp studies.

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100206

7 January 2021

The Short Insulin Tolerance Test for Determination of Insulin Sensitivity: A Comparison with the Euglycaemic Clamp

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100206

7 January 2021

Study of the rate of early glucose disappearance following insulin injection: insulin sensitivity index

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100206

7 January 2021

Reproducibility of the short insulin tolerance test

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100206

7 January 2021

A defect in insulin release in women at risk of future non-insulin-dependent diabetes

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100206

7 January 2021

Postprandial thermogenesis is reduced in polycystic ovary syndrome and is associated with increased insulin resistance

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100206

7 January 2021

A simple method for quantitation of insulin sensitivity and insulin release from an intravenous glucose tolerance test

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100206

7 January 2021

NMR as a metabolic tool

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100206

7 January 2021

Natural-abundance 13C NMR study of glycogen repletion in human liver and muscle

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100206

7 January 2021

Mechanism of liver glycogen repletion in vivo by nuclear magnetic resonance spectroscopy

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100206

7 January 2021

Direct observation of glycogen synthesis in human muscle with 13C NMR

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100206

7 January 2021

Quantitation of muscle glycogen synthesis in normal subjects and subjects with non-insulin-dependent diabetes by 13C nuclear magnetic resonance spectroscopy.

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100206

7 January 2021

Glucose-free fatty acid cycle operates in human heart and skeletal muscle in vivo

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100206

7 January 2021

Identifiers

DOI

10.1002/DMR.5610100206

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7956677%20AND%20SRC:MED&resulttype=core&format=json